A Four-Year, Open-Label, Multi-Center, Randomized, Two-Arm Study of Genotropin® in Patients with Idiopathic Short Stature: Comparison of an Individualized, Target-Driven Treatment Regimen to Standard Dosing of Genotropin® - Analysis of Two-Year Data | Zendy

Debra Counts | Zendy; Lawrence A. Silverman | Zendy; Mitchell E. Geffner | Zendy; Natasa Rajicic | Zendy; J. HeyHadavi | Zendy; Paul Thornton | Zendy; Michael P. Wajnrajch | Zendy

Open Access

A Four-Year, Open-Label, Multi-Center, Randomized, Two-Arm Study of Genotropin® in Patients with Idiopathic Short Stature: Comparison of an Individualized, Target-Driven Treatment Regimen to Standard Dosing of Genotropin® - Analysis of Two-Year Data

Author(s) -

Debra Counts,

Lawrence A. Silverman,

Mitchell E. Geffner,

Natasa Rajicic,

J. HeyHadavi,

Paul Thornton,

Michael P. Wajnrajch

Publication year - 2013

Publication title -

hormone research in paediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.816

H-Index - 89

eISSN - 1663-2826

pISSN - 1663-2818

DOI - 10.1159/000354126

Subject(s) - idiopathic short stature , dosing , medicine , bone age , percentile , regimen , clinical endpoint , growth hormone treatment , short stature , pediatrics , open label , randomized controlled trial , growth hormone , hormone , statistics , mathematics

Several models have been developed to predict growth response to growth hormone (GH) based on auxological and biochemical parameters for children with non-GH-deficient, idiopathic short stature (ISS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research